论文信息 - Individualized Angiotensin‐Converting Enzyme (ACE)‐Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model - 字舞流文

Individualized Angiotensin‐Converting Enzyme (ACE)‐Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model

M. Simoons | W. Remme | R. Ferrari | E. Boersma | R. Oemrawsingh | K. M. Akkerhuis | M. Bertrand | K. Fox | M. D. de Maat | W. Redekop | A. Danser | J. Brugts | G. Rudež | L. V. van Vark | K. Akkerhuis | Goran Rudež | A. Danser